DEANNA JUAREZ: Open Payments
NPI 1396959342 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 20 payments from 10 companies in 2025. Trend: 2023 $739 · 2024 $1,632 · 2025 $1,318
Food & beverage: $1,275Education: $43
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $326 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $263 |
| Abbott Laboratories | 4 | $214 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| Tandem Diabetes Care, Inc. | 1 | $106 |
| CeQur Corporation | 1 | $102 |
| Lilly USA, LLC | 1 | $93 |
| Mannkind Corporation | 1 | $43 |
| Soleno Therapeutics, Inc. | 1 | $31 |
| Corcept Therapeutics | 1 | $21 |
Products named: JARDIANCE, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, DEXCOM G7 GSS (161), Kerendia, t:slim X2 Insulin Pump with Control-IQ, CeQur Simplicity, MOUNJARO.
Industry payments across TX — which companies pay providers there.
